New Antibodies to Phospho Alpha Synuclein and Tau
Phospho Alpha Synuclein Antibodies
90% of the alpha-synuclein in Lewy bodies is phosphorylated at serine 129, which makes it a useful method for detecting disease pathology. The phosphorylation of serine 129 may also be related to the aggregation and toxicity of α-synuclein. neuroS provides monoclonal and polyclonal phosphorylated antibodies against pSer129α synuclein.
Phospho Tau Antibodies
Tau hyperphosphorylation precedes tau accumulation in tau accumulation (such as Alzheimer's disease), and may occur at multiple phosphorylation sites. Of particular interest is the phosphorylation at serine 202 and threonine 205, which induces turn-like structures and drives tau aggregation. neuroS provides monoclonal and polyclonal phosphorylated antibodies against phosphorylated Tau.
Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-Tau Monoclonal Antibody, Clone 1D5 (NAB2007FY658).
Tissue: Brain slice. Species: Mouse. Primary Antibody: Rabbit Anti-Tau Monoclonal Antibody (NAB2007FY661).
Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-Tau Monoclonal Antibody, Clone 1D5 (NAB2007FY658) in iPSC-derived neurons with MAPT P301L mutation.
Tissue: iPSC-derived neurons with MAPT P301L mutation. Species: Human. Primary Antibody: Mouse Anti-Tau Monoclonal Antibody (NAB2007FY658) (A) DAPI. (B) Total Tau Antibody. (C) NAB2007FY658. (D). Merge
Antibodies have been generated against active full length (2N4R) tau pre-formed fibrils (PFFs). NAB2007FY658 detects fibrils more strongly than monomers, and NAB2007FY659 detects both.
